Mycotoxigenicity of clinical and environmental Aspergillus fumigatus and A. flavus isolates

Acta Pharmaceutica

Volumn 55, Issue 4, 2005, Pages 365-375

  Kosalec, Ivan ^a   Pepeljnjak, Stjepan ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

A. Flavus; Aflatoxin; Aspergillus fumigatus; Gliotoxin; In vitro production; Moulds; Mycotoxin; Secondary metabolites

Indexed keywords

AFLATOXIN B1; AFLATOXIN G1; GLIOTOXIN; MYCOTOXIN;

AIR; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; BACILLUS SUBTILIS; BIOASSAY; COMPOST; CONFERENCE PAPER; CONTROLLED STUDY; ENVIRONMENT; FUNGAL STRAIN; FUNGUS ISOLATION; IMMUNE DEFICIENCY; MOULD; MYCOTOXICOSIS; NONHUMAN; SOIL; THIN LAYER CHROMATOGRAPHY;

EID: 29244483418     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. B. Dupont, M. Richardson, P. E. Verweij and F. G. M. Meis, Invasive aspergillosis, Med. Mycol. 38 (Suppl. 1) (2000) 215-224.
2. J. F. C. Tomee and H. F. Kauffman, Putative virulence factors of Aspergillus fumigatus, Clin. Exp. Allergy 30 (2000) 476-484.
3. L. H. Hogan, B. S. Klein and S. M. Levitz, Virulence factors of medically important fungi, Clin. Microbiol. Rev. 9 (1996) 469-488.
4. J. P. Large, Aspergillus fumigatus and aspergillosis, Clin. Microbiol. Rev. 12 (1999) 310-350.
5. S. Paris, D. Wysong, J. -P. Debeaupuis, K. Shibuya, B. Philippe, R. D. Diamond and J. -P. Large, Catalases of Aspergillus fumigatus, Infect. Immunol. 71 (2003) 3551-3562.
6. J. Bauer, M. Gareis, A. Bott and B. Gedek, Isolation of a mycotoxin (gliotoxin) from a bovine udder infected with Aspergillus fumigatus, J. Med. Vet. Myocol. 27 (1989) 45-50.
7. J. L. Richard and M. C. DeBey, Production of gliotoxin during the pathogenic state in turkey poults by Aspergillus fumigatus Fresenius, Mycopathologia 129 (1995) 111-115.
8. J. L. Richard, T. J. Dvorak and P. F. Ross, Natural occurrence of gliotoxin in turkeys infected with Aspergillus fumigatus, Fresenius, Mycopathologia 134 (1996) 167-170.
9. G. S. Bondy and J. J. Pestka, Immunomodulation by fungal toxins, J. Toxicol Environ. Health 3 (2000) 109-143.
10. rd ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy), Chicago, 14-17 September, 2003.
11. I. Kosalec and S. Pepeljnjak, The chemistry and biological effects of gliotoxin, Arh. Hig. Rada Toksikol. 55 (2004) 313-320.
12. P. Waring and J. Beaver, Gliotoxin and related epipolythiodioxopiperazines, Gen. Pharm. 27 (1996) 1311-1316.
13. P. Sutton, J. Beaver and P. Waring, Evidence that gliotoxin enhances lymphocyte activation and induces apoptosis by effects on cyclic AMP levels, Biochem. Pharmacol. 50 (1995) 2009-2014.
14. V. Cusumano, G. B. Costa and S. Seminara, Effects of aflatoxins on rat peritoneal macrophages, Appl. Environ. Microbiol. 56 (1990) 3482-3484.
15. G. J. Jakab, R. R. Hmieleski, A. Zarba, D. R. Hemenway and J. D. Groopman, Respiratory aflatoxicosis: suppression of pulmonary and systemic host defenses in rats and mice, Toxicol. Appl. Pharmacol. 125 (1994) 198-205.
16. D. M. Hinton, M. J. Myers, R. A. Raybourne, S. Francke-Varroll, R. E. Sotomayor, J. Shaddock, A. Warbritton and M. W. Chous, Immunotoxicity of aflatoxin Bl in inflammatory response in a chronic intermittent dosing study, Toxicol. Sci. 73 (2003) 362-377.
17. 1 on murine peritoneal macrophage functions, Toxicology 133 (1999) 171-179.
18. M. Birch, D. W. Denning and F. D. Robson, Comparison of extracellular phospholipase activities in clinical and environmental Aspergillus fumigatus isolates, Med. Mycol. 42 (2004) 81-86.
19. S. Pepeljnjak, Z. Slobodnjak, M. Šegvić, M. Peraica and M. Pavlovic, The ability of fungal isolates from human lung aspegilloma to produce mycotoxins, Human Exper. Toxicol. 23 (2004) 15-19.
20. nd ed. (Eds. G. S. deHoog and J. Guarro), Centraalbureau voor Schimmelcultures, Universitat Rovira i Virgili, Baard-Delft 2000.
21. M. A. Klich, Identification of common Aspergillus species, Centralbureau voor Schimmelcultures, Utrecht, 2002.
22. C. J. Land, H. Lundström and S. Werner, Production of tremorgenic mycotoxins by isolates of Aspergillus fumigatus from sawmills in Sweden, Mycopathologia 124 (1993) 87-93.
23. P. Sutton, N. R. Newcombe, P. Waring and A. Müllbacher, In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi, Infect. Immunol. 62 (1994) 1192-1198.
24. A. Aufauvre-Brown, J. S. Brown and D. W. Holden, Comparison of virulence between clinical and environmental isolates of Aspergillus fumigatus, Eur. J. Clin. Microbiol. Infect. Dis. 17 (1998) 778-780.
25. R. P. Hobson, The effects of diffusates from the spores of Aspergillus fumigatus and A. terreus on human neutrophils, Naegleria gruberi and Acanthomoeba castellanii, Med. Mycol. 38 (2000) 133-141.
26. K. Tepšič, N. Gunde-Cimerman and J. C. Frisvad, Growth and mycotoxin production by Aspergillus fumigatus strains isolated from a saltern, FEMS Microbiol. Lett. 157 (1997) 9-12.
27. G. Fischer, T. Muller, R. Schwalbe, R. Ostrowski and W. Dott. Exposure to airborne fungi, MVOC and mycotoxins in biowaste-handling facilities, Int. J. Hyg. Environ. Health 203 (2000) 97-104.
28. S. M. Nieminen, R. Kärki, S. Auriola, M. Toivola, H. Laatsch, R. Laatikainen, A. Hyvärinen and A. von Wright, Isolation and identification of Aspergillus fumigatus mycotoxins on growth medium and some building materials, Appl. Environ. Microbiol. 68 (2002) 4871-4875.
29. D. T. Shah and B. Larsen, Clinical isolates of yeast produce a gliotoxin-like substance, Mycopathologia 116 (1991) 203-208.